Tian K, Han J, Wang Z, Chen J, et al. Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis. Oral Oncol 2022;128:105842.
PMID: 35428025